Ovulation Testing Kits Market (2026 - 2033)

Ovulation Testing Kits Market Summary

The global ovulation testing kits market size was valued at USD 3.4 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 6.3 billion by 2033, at a CAGR of 7.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 38.0% in 2025. The global market's growth is attributed to factors such as the increasing prevalence of polycystic ovary syndrome (PCOS) and other hormonal disorders affecting women of reproductive age.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Furthermore, the market is anticipated to be driven by an increase in the age at first pregnancy, declining fertility rates globally, and technological advancements. The primary drivers of this market growth include the increasing success rates of IVF technology, rising awareness regarding IVF procedures, and a trend toward delayed onset of pregnancy. The growing awareness of advanced in vitro fertilization (IVF) techniques and the improving IVF success rates have generated a demand for ovulation kits globally. According to the World Health Organization (WHO), approximately 17.5% of adults globally, or nearly 1 in 6 people, experience infertility during their lifetime, highlighting the substantial global need for fertility care and reproductive health management. The growing number of individuals seeking to understand their fertility and improve the timing of conception is expected to drive the adoption of at-home ovulation testing kits, which help identify the fertile window.

The increasing prevalence and diagnosis of polycystic ovary syndrome (PCOS) is another factor supporting market growth. PCOS is associated with irregular or absent ovulation and is a leading cause of infertility among women. According to the WHO fact sheet updated in January 2026, PCOS affects an estimated 10–13% of reproductive-aged women globally, while up to 70% of affected women may remain undiagnosed. As awareness, diagnosis, and fertility management among women with PCOS increase, demand for fertility-monitoring and ovulation-tracking solutions is expected to rise.

Manufacturers are increasingly investing in the development of more accurate, convenient, and user-friendly ovulation testing products. Product innovation includes digital interpretation of results, integration with smartphone-based fertility-tracking applications, improved hormone detection, and more convenient test formats. These developments are helping improve the usability of at-home fertility monitoring and are particularly relevant as consumers increasingly seek convenient alternatives to clinical fertility monitoring.

Analyst Perspective

The ovulation testing kits market is shifting from basic LH test strips toward more convenient, digitally enabled, and consumer-centric fertility-monitoring solutions. Urine-based tests will continue to account for the largest share due to their affordability and accessibility, while digital tests are expected to gain share through clearer interpretation of results, app connectivity, and personalized cycle tracking. At the distribution level, e-commerce is becoming increasingly important due to discreet purchasing, product variety, and doorstep delivery. Regionally, North America is expected to remain the largest market, while Asia Pacific is likely to deliver the fastest growth as fertility awareness, healthcare access, and adoption of at-home reproductive health testing increase.

Product Insights

The urine ovulation test segment dominated the global market in 2025, accounting for the largest revenue share at around 49.0%. The growth is attributed to a high level of accuracy in determining the presence or absence of hCG (human chorionic gonadotropin), an indicator of pregnancy. The increase in the patients' inclinations towards self-monitoring of medical conditions is attributed to the accessibility and user-friendly nature of at-home testing equipment. For instance, companies now provide ovulation prediction kits designed for home use, allowing individuals to assess the presence of ovulation-related hormones in saliva or urine. This is expected to boost the demand for ovulation kits during the forecast period.

Digital ovulation test is anticipated to register the fastest CAGR over the forecast period. The emergence of digital ovulation test kits is anticipated to provide startups with a solid foundation that helps establish their presence in the market. Some digital ovulation tests have built-in memory or smartphone app connectivity, allowing users to track their fertility over time and gain insights into their menstrual cycles. Such features in digital kits are anticipated to increase the demand for these innovative kits. Furthermore, the evolving landscape of healthcare regulations is creating favorable conditions for new entrants to gain access to these opportunities.

Distribution Channel Insights

Based on distribution channel, the market is segmented into pharmacies and drugstores, hypermarkets and supermarkets, and e-commerce segments. The pharmacies and drugstores segment dominated the global market in 2025, accounting for approximately 38.0% of revenue. Its leading position can be attributed to the widespread availability of fertility and reproductive health products through established pharmacy networks, particularly in emerging markets such as India, China, and Brazil. Pharmacies also offer consumers convenient access to over-the-counter testing products and provide an additional level of trust and guidance when selecting fertility-monitoring solutions.

The e-commerce segment is expected to register the fastest CAGR during the forecast period. Increasing consumer preference for purchasing fertility products from home, coupled with growing internet and smartphone penetration, is supporting the shift toward online channels. E-commerce platforms offer discreet purchasing and home delivery, which can be particularly attractive for reproductive health products. In addition, online channels provide access to a broader range of urine-based and digital ovulation testing kits across different price points and product formats. The growing adoption of direct-to-consumer fertility products and the integration of digital ovulation tests with smartphone-based fertility tracking are expected to further strengthen online sales.

Regional Insights

The ovulation testing kits industry in North America dominated the global market in 2025, accounting for around 38.0% of revenue. This can be attributed to the increasing demand for ovulation test kits, due to the availability of advanced features such as Bluetooth connectivity and smart countdown functions. The presence of a working-class population in the United States is contributing to the increase in unit sales of ovulation test kits, as they often have limited time to visit a healthcare provider. This factor further enhances the regional market. Moreover, manufacturers in the region are focusing on developing more accurate, affordable, user-friendly, and reliable ovulation testing solutions to meet growing consumer demand for at-home fertility monitoring. Leading players are also pursuing product innovation and strategic collaborations to strengthen their portfolios and expand their presence in the region. For instance, Clearblue offers advanced digital ovulation tests that incorporate dual-hormone detection technology, measuring both estrogen and luteinizing hormone (LH) to identify a broader fertile window than conventional LH-only tests. Such innovations are supporting the shift toward more sophisticated and convenient fertility-monitoring solutions and are expected to contribute to the growth of the digital ovulation test segment in North America.

To learn more about this report, Download Free Sample Report

Asia Pacific Ovulation Testing Kits Market Trends

The ovulation testing kits industry in Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Market growth in the region is being driven by the increasing prevalence of lifestyle-related disorders that can affect reproductive health, along with growing awareness of fertility monitoring and conception planning. The increasing availability of ovulation test kits, rising investments in fertility-monitoring technologies, and expanding access to at-home testing solutions are expected to support demand across countries in the region. In addition, rising disposable incomes, delayed or first-time pregnancies, declining fertility rates, and ongoing advancements in ovulation testing technologies are contributing to greater adoption of convenient fertility-monitoring products.

Key Ovulation Testing Kits Company Insights

The market players are adopting various strategies, such as new service launches, partnerships & collaborations, and regional expansion to gain higher shares.

Key Ovulation Testing Kits Companies

The following key companies have been profiled for this study on the ovulation testing kits market:

• Swiss Precision Diagnostics GmbH

• Proov

• Easy@Home Fertility

• Church & Dwight Co., Inc.

• Piramal Pharma Ltd

• Wondfo

• Accuquik

• Fairhaven Health

• PREGMATE

• Mira

Recent Developments

• In June 2026, Clearblue expanded its smart ovulation testing offering with its camera-read Smart Ovulation Test, which integrates with the Clearblue Period Cycle Tracker app. The test uses an adaptive algorithm to detect luteinizing hormone (LH) surges and identify the user's two most fertile days. Test results can be captured, analyzed, and stored through the app, highlighting the growing integration of digital technologies and personalized fertility tracking into home-based ovulation testing.

• In August 2025, Mira launched Ultra4, an at-home hormone monitor capable of measuring four reproductive hormones, FSH, LH, E3G, and PdG, from a single test wand. The product provides users with a more comprehensive view of hormonal changes throughout the menstrual cycle and reflects the industry's shift toward multi-hormone, personalized, and data-driven fertility monitoring solutions.

Global Ovulation Testing Kits Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ovulation testing kits market report based on product, distribution channel, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Urine Ovulation Test
    • Test Strip Type
    • Cassette Type
    • Midstream Type
  • Digital Ovulation Test
  • Saliva Ovulation Test
• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hypermarkets and Supermarkets
  • E-Commerce
  • Pharmacies and Drugstores
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait